Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

Giving a special protein to dogs with a certain genetic disease improved their symptoms but didn't help with hair growth.

Calcium blockers may help prevent hearing loss by protecting hair cells.

Lokivetmab reduced itching in a dog with skin lymphoma.

Clascoterone cream could be used for other skin conditions affected by hormones.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Removing β-catenin in certain stem cells causes hair whitening and pigmentation issues.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ocrelizumab may cause pancreatitis in some patients.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

ITK inhibitors may effectively treat alopecia areata.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.